Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 4 (2008), Issue 1 (January)

1. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data.
   Crit Care Med, 36(1): 100-7. [Abstract] [Full-text]
2. Cue-responding behaviours of oncology nurses in video-simulated interviews.
   J Adv Nurs, 61(1): 71-80. [Abstract] [Full-text]
3. Dental extractions and radiotherapy in head and neck oncology: review of the literature.
   Oral Dis, 14(1): 40-4. [Abstract] [Full-text]
4. A Phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149).
   J Neurooncol, 86(3): 353-8. [Abstract] [Full-text]
5. Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer A retrospective analysis of the Southern Italy Cooperative Oncology Group trials.
   Crit Rev Oncol Hematol, 65(2): 164-71. [Abstract] [Full-text]
6. Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology.
   Anticancer Drugs, 19(2): 221-33. [Abstract] [Full-text]
7. The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond.
   Value Health. [Abstract] [Full-text]
8. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the american society of clinical oncology.
   J Clin Oncol, 26(2): 313-25. [Abstract] [Full-text]
9. Liver embolizations in oncology: A review : Part I. Arterial (chemo)embolizations.
   Med Oncol, 25(1): 1-11. [Abstract] [Full-text]
10. Designing a mixed methods study in pediatric oncology nursing research.
    J Pediatr Oncol Nurs, 25(1): 24-33. [Abstract] [Full-text]
11. An exploratory survey of nurses' perceptions of phase I clinical trials in pediatric oncology.
    J Pediatr Oncol Nurs, 25(1): 14-23. [Abstract] [Full-text]
12. Residents' perspectives on surgical training and the resident-fellow relationship: comparing residency programs with and without gynecological oncology fellowships.
    Int J Gynecol Cancer, 18(1): 199-204. [Abstract] [Full-text]
13. Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases.
    J Vasc Interv Radiol, 19(1): 80-7. [Abstract] [Full-text]
14. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells Wang H, McKnight NC, Zhang T, Lu ML, Balk SP, Yuan X, Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Urology Research Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
    Urol Oncol, 26(1): 110-1. [Abstract] [Full-text]
15. Prognostic significance of erythropoietin expression in human renal cell carcinoma Michael A, Politi E, Havranek E, Corbishley C, Karapanagiotou L, Anderson C, Relph K, Syrigos KN, Pandha H, Department of Oncology, St. George's Hospital Medical School, London, UK.
    Urol Oncol, 26(1): 106. [Abstract] [Full-text]
16. A prospective randomized EORTC intergroup Phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, Claessens I, Sylvester R, European Organization for Research and Treatment of Cancer (EORTC); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Southwest Oncology Group (SWOG); Eastern Cooperative Oncology Group (ECOG). Department of Urology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.
    Urol Oncol, 26(1): 101-2. [Abstract] [Full-text]
17. Quantum dots: emerging applications in urologic oncology.
    Urol Oncol, 26(1): 86-92. [Abstract] [Full-text]
18. Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG).
    Breast Cancer Res Treat. [Abstract] [Full-text]
19. A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
    Pediatr Blood Cancer, 50(3): 577-80. [Abstract] [Full-text]
20. Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report.
    Pediatr Blood Cancer, 50(3): 533-6. [Abstract] [Full-text]
21. Are Phase 2 screening trials in oncology obsolete?
    Stat Med, 27(4): 556-67. [Abstract] [Full-text]
22. Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study.
    Pediatr Blood Cancer, 50(3): 549-53. [Abstract] [Full-text]
23. Participants in phase 1 oncology research trials: are they vulnerable?
    Arch Intern Med, 168(1): 16-20. [Abstract] [Full-text]
24. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group.
    Horm Res, 69(2): 65-74. [Abstract] [Full-text]
25. Burnout, staff support, and coping in Pediatric Oncology.
    Support Care Cancer, 16(2): 143-150. [Abstract] [Full-text]
26. Guiding research in family care: a new approach to oncology caregiving.
    Psychooncology. [Abstract] [Full-text]
27. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.
    J Clin Oncol, 26(3): 463-7. [Abstract] [Full-text]
28. Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.
    J Clin Oncol, 26(3): 414-20. [Abstract] [Full-text]
29. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study.
    J Clin Oncol, 26(3): 399-405. [Abstract] [Full-text]
30. Multicentre assessment and monitored use of [(18)F]FDG-PET in oncology: the Spanish experience.
    Eur J Nucl Med Mol Imaging, 35(2): 296-304. [Abstract] [Full-text]
31. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Int J Radiat Oncol Biol Phys, 70(2): 353-60. [Abstract] [Full-text]
32. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
    Int J Radiat Oncol Biol Phys, 70(2): 437-41. [Abstract] [Full-text]
33. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 70(2): 385-90. [Abstract] [Full-text]
34. Computer-assisted bar-coding system significantly reduces clinical laboratory specimen identification errors in a pediatric oncology hospital.
    J Pediatr, 152(2): 219-24. [Abstract] [Full-text]
35. Mammalian target of rapamycin as a therapeutic target in oncology.
    Expert Opin Ther Targets, 12(2): 209-22. [Abstract] [Full-text]
36. Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.
    Psychosomatics, 49(1): 56-63. [Abstract] [Full-text]
37. Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the hellenic cooperative oncology group.
    Oncology, 72(3): 211-8. [Abstract] [Full-text]
38. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
    Ann Surg, 247(2): 315-9. [Abstract] [Full-text]
39. The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.
    Mod Pathol, 21(2): 165-77. [Abstract] [Full-text]
40. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
    Blood, 111(3): 1044-53. [Abstract] [Full-text]
41. Smoking cessation and lung cancer: oncology nurses can make a difference.
    Semin Oncol Nurs, 24(1): 16-26. [Abstract] [Full-text]
42. Stop the pain! A nation-wide quality improvement programme in paediatric oncology pain control.
    Eur J Pain. [Abstract] [Full-text]
43. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes.
    J Pain Symptom Manage, 35(2): 162-70. [Abstract] [Full-text]
44. Infections caused by coryneform bacteria in pediatric oncology patients.
    Pediatr Infect Dis J, 27(2): 136-41. [Abstract] [Full-text]
45. Troponin in hematologic oncology.
    Leuk Lymphoma, 49(2): 194-203. [Abstract] [Full-text]
46. Gynecologic oncology: the German view.
    Arch Gynecol Obstet. [Abstract] [Full-text]
47. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.
    J Clin Oncol, 26(4): 644-9. [Abstract] [Full-text]
48. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    J Clin Oncol, 26(4): 633-8. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.